CDx Diagnostics® provides clinicians with cost-effective tools to detect precancerous changes early using AI
|
Founded year:
|
2010
|
|
Country:
|
United States of America
|
|
Funding rounds:
|
Not set
|
|
Total funding amount:
|
Not set
|
Description
CDx Diagnostics® provides clinicians with cost-effective tools to detect precancerous changes early using AI, computer imaging, and WATS3D cytopathology. These tests are quick, widely reimbursed, and address critical diagnostic gaps, saving lives by identifying precancerous cells missed by other methods.
